Estados financieros detallados de COMPASS Pathways plc (CMPS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $13.80, CMPS presenta beneficios negativos (P/E no significativo) y un ROE del -398.21%. La capitalización bursátil es de $1.9B.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $63000 | $112871 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$63000 | -$112871 | 0 | 0 | 0 | 0 | 0 |
| I+D | $8.9M | $12.6M | $23.4M | $44.0M | $65.1M | $87.5M | $119.0M | $118.4M |
| Generales y Administrativos | $3.6M | $8.6M | $28.0M | $39.2M | $45.4M | $49.4M | $59.2M | $60.6M |
| Gastos Operativos | $12.5M | $21.2M | $51.7M | $83.2M | $110.4M | $136.9M | $178.2M | $179.0M |
| Beneficio Operativo | -$12.5M | -$21.2M | -$51.8M | -$83.2M | -$110.4M | -$136.9M | -$178.2M | -$179.0M |
| EBITDA | -$10.5M | -$22.3M | -$64.9M | -$71.4M | -$90.8M | -$115.2M | -$148.8M | -$285.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | $2.2M | $4.5M | $4.5M |
| Beneficio Antes de Impuestos | -$13.2M | -$19.6M | -$65.0M | -$71.5M | -$91.1M | -$117.7M | -$153.5M | -$290.3M |
| Impuestos | 0 | $15000 | -$4.2M | $199000 | $408000 | $780000 | $1.6M | -$2.5M |
| Beneficio Neto | -$13.2M | -$19.6M | -$60.8M | -$71.7M | -$91.5M | -$118.5M | -$155.1M | -$287.9M |
| BPA | $-2.35 | $-0.90 | $-1.68 | $-1.79 | $-2.16 | $-2.32 | $-2.30 | $-3.08 |
| BPA Diluido | $-2.35 | $-0.90 | $-1.68 | $-1.79 | $-2.16 | $-2.32 | $-2.30 | $-3.08 |
| Acciones en Circulación (Diluidas) | $5.6M | $21.7M | $35.9M | $40.0M | $42.4M | $51.0M | $67.5M | $93.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$40.5M | -$46.0M | -$42.9M | -$52.4M |
| EBITDA | -$136.8M | -$95.5M | $92.7M | -$252.0M |
| Beneficio Neto | -$137.7M | -$93.9M | $91.2M | -$253.8M |
| BPA | $-1.44 | $-1.00 | $-0.42 | $-2.71 |
| BPA Diluido | $-1.44 | $-1.00 | $-0.42 | $-2.71 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $22.9M | $25.0M | $190.3M | $273.2M | $143.2M | $220.2M | $165.1M | $149.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $2.1M | 0 | 0 | $11.2M | $15.6M | $28.9M | $21.8M | $15.4M |
| Inventario | $943000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $26.3M | $32.2M | $202.4M | $295.3M | $191.7M | $261.3M | $201.3M | $191.5M |
| Inmovilizado Material | $108000 | $218000 | $245000 | $4.1M | $2.6M | $4.7M | $2.2M | $3.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $26.4M | $32.4M | $203.5M | $300.9M | $197.3M | $276.0M | $213.7M | $210.3M |
| Cuentas por Pagar | $694000 | $1.3M | $2.7M | $2.6M | $4.8M | $5.9M | $12.3M | $15.2M |
| Deuda a Corto | 0 | $21.1M | 0 | 0 | 0 | 0 | $5.5M | $19.6M |
| Pasivos Corrientes | $1.8M | $23.9M | $6.9M | $15.1M | $15.6M | $19.6M | $34.0M | $247.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $28.8M | $24.7M | $1.3M |
| Pasivos Totales | $40.8M | $23.9M | $6.9M | $16.5M | $16.0M | $50.2M | $59.0M | $263.2M |
| Reservas | -$18.0M | -$37.6M | -$97.9M | -$169.6M | -$261.1M | -$379.6M | -$534.7M | -$822.6M |
| Patrimonio Neto | -$14.4M | $8.5M | $196.6M | $284.4M | $181.3M | $225.7M | $154.7M | -$52.8M |
| Deuda Total | 0 | $21.1M | 0 | $3.6M | $1.9M | $33.0M | $32.2M | $20.9M |
| Deuda Neta | -$22.9M | -$3.9M | -$190.3M | -$269.6M | -$141.3M | -$187.1M | -$132.9M | -$128.7M |
| Capital Circulante | $24.4M | $8.3M | $195.5M | $280.2M | $176.1M | $241.7M | $167.3M | -$56.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $185.9M | $149.6M | $466.0M | $433.3M |
| Activos Totales | $255.6M | $210.3M | $531.7M | $504.6M |
| Pasivos Totales | $218.0M | $263.2M | $205.1M | $420.0M |
| Patrimonio Neto | $37.6M | -$52.8M | $326.7M | $84.5M |
| Deuda Total | $35.2M | $35.0M | $2.8M | $54.6M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$13.2M | -$19.6M | -$60.3M | -$71.7M | -$91.5M | -$118.5M | -$155.1M | -$287.9M |
| Amortizaciones | $22000 | $63000 | $112000 | $175000 | $330000 | $242000 | $233000 | $216000 |
| Compensación en Acciones | $1.4M | $3.3M | $18.0M | $8.6M | $13.1M | $17.3M | $19.5M | $13.6M |
| Cambio en Capital Circulante | -$704000 | -$2.7M | -$912000 | -$6.6M | -$30.7M | $3.5M | $11.7M | -$14.3M |
| Flujo de Caja Operativo | -$9.8M | -$17.8M | -$41.4M | -$67.7M | -$105.5M | -$97.4M | -$119.2M | -$157.2M |
| Inversiones (CapEx) | -$130000 | -$165000 | -$131000 | -$334000 | -$596000 | -$66000 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$9.9M | -$18.0M | -$41.5M | -$68.1M | -$106.0M | -$97.4M | -$119.2M | -$157.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$35.1M | -$37.8M | -$47.9M | -$40.3M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$35.1M | -$37.8M | -$47.9M | -$40.3M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.2M | $2.9M | $2.9M | $4.0M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -48.4% | -210.0% | -18.0% | -27.5% | -29.5% | -30.9% | -85.6% |
| Crecimiento BPA (anual) | | +61.7% | -86.7% | -6.5% | -20.7% | -7.4% | +0.9% | -33.9% |
| Cambio en Acciones (anual) | | +286.6% | +65.4% | +11.3% | +6.1% | +20.2% | +32.2% | +38.6% |
| Crecimiento FCF (anual) | | -81.0% | -130.9% | -64.0% | -55.8% | +8.1% | -22.3% | -31.9% |
| Tasa Impositiva Efectiva | -0.0% | -0.1% | 6.5% | -0.3% | -0.4% | -0.7% | -1.0% | 0.9% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-1.77 | $-0.83 | $-1.16 | $-1.70 | $-2.50 | $-1.91 | $-1.77 | $-1.68 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $5.6M | $21.7M | $35.9M | $40.0M | $42.4M | $51.0M | $67.5M | $93.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -398.21% |
| Rentabilidad sobre capital invertido | -129.74% |
| Rentabilidad sobre activos | -78.12% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.65 |
| Ratio corriente | 1.30 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -12.34 | -32.22 | -28.36 | -12.35 | -3.72 | -3.77 | -1.64 | -2.24 |
| P/VC | -11.34 | 73.96 | 8.71 | 3.11 | 1.88 | 1.98 | 1.65 | -12.21 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |